Legend Biotech Corp Cash And Cash Equivalents
Legend Biotech Corp (LEGN) had Cash And Cash Equivalents of $901.90 million as of 2025-12-31, per its 20-F filed 2026-03-10.
Financial Statements › Notes
ifrs-full:CashAndCashEquivalents · last filed 2026-03-10
- 2025-12-31: Cash And Cash Equivalents $901.90M.
- 2025-09-30: Cash And Cash Equivalents $278.89M.
- 2025-06-30: Cash And Cash Equivalents $266.59M.
- 2025-03-31: Cash And Cash Equivalents $441.70M.
| Period end | Cash And Cash Equivalents | Cash And Cash Equivalents as first filed |
|---|---|---|
| 2025-12-31 | $901.90M 20-F · filed 2026-03-10 | |
| 2025-09-30 | $278.89M 6-K · filed 2025-11-12 | |
| 2025-06-30 | $266.59M 6-K · filed 2025-08-11 | |
| 2025-03-31 | $441.70M 6-K · filed 2025-05-13 | |
| 2024-12-31 | $286.70M 20-F · filed 2026-03-10 | $286.75M 20-F · filed 2025-03-11 |
| 2024-09-30 | $459.28M 6-K · filed 2025-11-12 | |
| 2024-06-30 | $201.25M 6-K · filed 2025-08-11 | |
| 2024-03-31 | $897.57M 6-K · filed 2025-05-13 | |
| 2023-12-31 | $1.28B 20-F · filed 2026-03-10 | $1.28B 20-F · filed 2024-03-19 |
| 2023-09-30 | $963.47M 6-K · filed 2024-11-12 | |
| 2023-06-30 | $1.23B 6-K · filed 2024-08-09 | |
| 2023-03-31 | $660.05M 6-K · filed 2024-05-13 | |
| 2022-12-31 | $786.00M 20-F · filed 2026-03-10 | $786.03M 20-F · filed 2023-03-30 |
| 2022-09-30 | $812.73M 6-K · filed 2023-11-20 | |
| 2022-06-30 | $379.78M 6-K · filed 2023-08-15 | |
| 2021-12-31 | $688.94M 20-F · filed 2025-03-11 | |
| 2021-06-30 | $488.21M 6-K · filed 2021-08-23 | |
| 2020-12-31 | $455.69M 20-F · filed 2024-03-19 | |
| 2020-06-30 | $562.39M 6-K · filed 2021-08-23 | |
| 2020-01-01 | $83.36M 20-F/A · filed 2023-02-17 | |
| 2019-12-31 | $83.36M 20-F · filed 2023-03-30 | |
| 2018-12-31 | $210.17M 20-F/A · filed 2023-02-17 | |
| 2017-12-31 | $2.12M 20-F · filed 2021-04-02 |